In their secondary analysis of the Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma randomized clinical trial, researchers evaluated the 5-year efficacy of...
A phase 3 trial evaluating apremilast in children and adolescents with moderate-to-severe plaque psoriasis showed improvements in disease severity compared with placebo over 16 weeks.
A ceramide and niacinamide-containing moisturizer (CCM) significantly enhances acne treatment outcomes by reducing lesions and improving skin barrier function when used alongside standard anti-acne...
A recent phase 3b long-term extension study assessed the safety and efficacy of deucravacitinib over 2 years in patients with moderate-to-severe plaque psoriasis.
Researchers evaluated the association between two surgical excision approaches and overall survival for patients with pathologically confirmed, localized, early-stage Merkel cell carcinoma.
Despite being approved for use, consensus among the real-world data on the use of IL-23 inhibitors in psoriatic disease has been lacking; therefore, researchers recently examined the drug survival and...
In a retrospective cohort study, researchers investigated the treatment patterns for adults in the United States with alopecia areata from 2015 to 2020.
To better understand the potential benefits of secukinumab use in patients with psoriatic arthritis, researchers examined the proportion of patients being treated with secukinumab that achieved low disease...
